Abstract
Safe and effective delivery of DNA to post-mitotic cells, especially highly differentiated cells, remains a challenge despite significant progress in the development of gene delivery tools. Biodegradable polymeric nanoparticles (NPs) offer an array of advantages for gene delivery over viral vectors due to improved safety, carrying capacity, ease of manufacture, and cell-type specificity. Here we demonstrate the use of a high-throughput screening (HTS) platform to synthesize and screen a library of 148 biodegradable polymeric nanoparticles, successfully identifying structures that enable efficient transfection of human pluripotent stem cell differentiated human retinal pigment epithelial (RPE) cells with minimal toxicity. These NPs can deliver plasmid DNA (pDNA) to RPE monolayers more efficiently than leading commercially available transfection reagents. Novel synthetic polymers are described that enable high efficacy non-viral gene delivery to hard-to-transfect polarized human RPE monolayers, enabling gene loss- and gain-of-function studies of cell signaling, developmental, and disease-related pathways. One new synthetic polymer in particular, 3,3′-iminobis(N,N-dimethylpropylamine)-end terminated poly(1,5-pentanediol diacrylate-co-3 amino-1-propanol) (5–3-J12), was found to form self-assembled nanoparticles when mixed with plasmid DNA that transfect a majority of these human post-mitotic cells with minimal cytotoxicity. The platform described here can be utilized as an enabling technology for gene transfer to human primary and stem cell-derived cells, which are often fragile and resistant to conventional gene transfer approaches.
Lay Summary
Many retinal diseases are attributable to dysregulation in gene expression or lack of expression of specific genes, allowing for the possibility of prevention or cure of these diseases by effective delivery of nucleic acids coding for the necessary gene to the retina. Delivery of nucleic acids to cells of the retina is challenging due to the non-dividing nature of most retinal cells, preventing DNA from reaching the nucleus. To overcome this barrier, we engineered and tested a library of nanoparticle formulations to identify polymers that enabled safe and effective delivery of nucleic acid cargoes to retinal pigment epithelial cells. The nanoparticle technology explored here has the potential to be utilized for therapeutic delivery of nucleic acids to retinal cells, possibly enabling treatment for otherwise untreatable retinal diseases for which a specific genetic deficit is known but no drugs are available.
Similar content being viewed by others
References
Trapani I, Auricchio A. Seeing the light after 25 years of retinal gene therapy. Trends Mol Med. 2018;24(8):669–81.
Kotterman MA, Schaffer DV. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet. 2014;15(7):nrg3742.
Bitner H, Mizrahi-Meissonnier L, Griefner G, Erdinest I, Sharon D, Banin E. A homozygous frameshift mutation in BEST1 causes the classical form of BEST disease in an autosomal recessive mode. Invest Ophthalmol Vis Sci. 2011;52(8):5332–8.
den Hollander AI, Roepman R, Koenekoop RK, Cremers FPM. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27(4):391–419.
Liu X, Bulgakov OV, Darrow KN, Pawlyk B, Adamian M, Liberman MC, et al. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proc Natl Acad Sci U S A. 2007;104(11):4413–8.
Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther. 2006;17(3):253–63.
Wright JF. Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Ther. 2008;15(11):840–8.
Asokan A, Schaffer DV, Samulski RJ. The AAV vector toolkit: poised at the clinical crossroads. Mol Ther. 2012;20(4):699–708.
Oliveira AV, Rosa da Costa AM, Silva GA. Non-viral strategies for ocular gene delivery. Mater Sci Eng C Mater Biol Appl. 2017;77:1275–89.
Boylan NJ, Kim AJ, Suk JS, Adstamongkonkul P, Simons BW, Lai SK, et al. Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-L-lysine. Biomaterials. 2012;33(7):2361–71.
Cheng W, Yang C, Hedrick JL, Williams DF, Yang YY, Ashton-Rickardt PG. Delivery of a granzyme B inhibitor gene using carbamate-mannose modified PEI protects against cytotoxic lymphocyte killing. Biomaterials. 2013;34(14):3697–705.
de la Fuente M, Raviña M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev. 2010;62(1):100–17.
Kim TH, Park IK, Nah JW, Choi YJ, Cho CS. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials. 2004;25(17):3783–92.
Read ML, Singh S, Ahmed Z, Stevenson M, Briggs SS, Oupicky D, et al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. 2005;33(9):e86.
Wang H, Shi HB, Yin SK. Polyamidoamine dendrimers as gene delivery carriers in the inner ear: how to improve transfection efficiency. Exp Ther Med. 2011;2(5):777–81.
Yu H, Russ V, Wagner E. Influence of the molecular weight of bioreducible oligoethylenimine conjugates on the polyplex transfection properties. AAPS J. 2009;11(3):445–55.
Hornstein BD, Roman D, Arévalo-Soliz LM, Engevik MA, Zechiedrich L. Effects of circular DNA length on transfection efficiency by electroporation into HeLa cells. PLoS One. 2016;11(12):e0167537.
Vaughan EE, DeGiulio JV, Dean DA. Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import. Curr Gene Ther. 2006;6(6):671–81.
Bishop CJ, Majewski RL, Guiriba TRM, Wilson DR, Bhise NS, Quiñones-Hinojosa A, et al. Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry. Acta Biomater. 2016;37:120–30.
Yang F, Green JJ, Dinio T, Keung L, Cho SW, Park H, et al. Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Ther. 2009;16(4):533–46.
Sunshine JC, Sunshine SB, Bhutto I, Handa JT, Green JJ. Poly(beta-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One. 2012;7(5):e37543.
Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85(3):845–81.
Rodrigues GA, Shalaev E, Karami TK, Cunningham J, Slater NKH, Rivers HM. Pharmaceutical development of AAV-based gene therapy products for the eye. Pharm Res. 2018;36(2):29.
McClements ME, MacLaren RE. Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes. Yale J Biol Med. 2017;90(4):611–23.
Moore NA, Morral N, Ciulla TA, Bracha P. Gene therapy for inherited retinal and optic nerve degenerations. Expert Opin Biol Ther. 2018;18(1):37–49.
Planul A, Dalkara D. Vectors and gene delivery to the retina. Annu Rev Vis Sci. 2017;3:121–40.
Abul-Hassan K, Walmsley R, Boulton M. Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells. Curr Eye Res. 2000;20(5):361–6.
Bejjani RA, BenEzra D, Cohen H, Rieger J, Andrieu C, Jeanny JC, et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis. 2005;11:124–32.
Chaum E, Hatton MP, Stein G. Polyplex-mediated gene transfer into human retinal pigment epithelial cells in vitro. J Cell Biochem. 1999;76(1):153–60.
Jayaraman MS, et al. Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration. Mol Vis. 2012;18:2300–8.
Liu HA, Liu YL, Ma ZZ, Wang JC, Zhang Q. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model. Invest Ophthalmol Vis Sci. 2011;52(7):4789–94.
Mannermaa E, Rönkkö S, Ruponen M, Reinisalo M, Urtti A. Long-lasting secretion of transgene product from differentiated and filter-grown retinal pigment epithelial cells after nonviral gene transfer. Curr Eye Res. 2005;30(5):345–53.
Mannisto M, et al. The role of cell cycle on polyplex-mediated gene transfer into a retinal pigment epithelial cell line. J Gene Med. 2005;7(4):466–76.
Mannisto M, et al. Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release. 2002;83(1):169–82.
Peeters L, Sanders NN, Jones A, Demeester J, de Smedt SC. Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells. J Control Release. 2007;121(3):208–17.
Peng CH, Cherng JY, Chiou GY, Chen YC, Chien CH, Kao CL, et al. Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials. 2011;32(34):9077–88.
Bishop CJ, Ketola TM, Tzeng SY, Sunshine JC, Urtti A, Lemmetyinen H, et al. The effect and role of carbon atoms in poly(beta-amino ester)s for DNA binding and gene delivery. J Am Chem Soc. 2013;135(18):6951–7.
Maruotti J, Wahlin K, Gorrell D, Bhutto I, Lutty G, Zack DJ. A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med. 2013;2(5):341–54.
Maruotti J, Sripathi SR, Bharti K, Fuller J, Wahlin KJ, Ranganathan V, et al. Small-molecule-directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells. Proc Natl Acad Sci U S A. 2015;112(35):10950–5.
Gamm DM, Melvan JN, Shearer RL, Pinilla I, Sabat G, Svendsen CN, et al. A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2008;49(2):788–99.
Wilson DR, Green JJ. Nanoparticle Tracking Analysis for Determination of Hydrodynamic Diameter, Concentration, and Zeta-Potential of Polyplex Nanoparticles, in Biomedical Nanotechnology: Springer; 2017. p. 31–46.
Tzeng SY, Wilson DR, Hansen SK, Quiñones-Hinojosa A, Green JJ. Polymeric nanoparticle-based delivery of TRAIL DNA for cancer-specific killing. Bioeng Transl Med. 2016;1(2):149–59.
Shcherbakova DM, Verkhusha VV. Near-infrared fluorescent proteins for multicolor in vivo imaging. Nat Methods. 2013;10:751–4.
Tzeng SY, Guerrero-Cázares H, Martinez EE, Sunshine JC, Quiñones-Hinojosa A, Green JJ. Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma. Biomaterials. 2011;32(23):5402–10.
Green JJ, Zhou BY, Mitalipova MM, Beard C, Langer R, Jaenisch R, et al. Nanoparticles for gene transfer to human embryonic stem cell colonies. Nano Lett. 2008;8(10):3126–30.
Eltoukhy AA, Siegwart DJ, Alabi CA, Rajan JS, Langer R, Anderson DG. Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity. Biomaterials. 2012;33(13):3594–603.
Bishop CJ, Ketola TM, Tzeng SY, Sunshine JC, Urtti A, Lemmetyinen H, et al. The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. J Am Chem Soc. 2013;135(18):6951–7.
Zugates GT, Peng W, Zumbuehl A, Jhunjhunwala S, Huang YH, Langer R, et al. Rapid optimization of gene delivery by parallel end-modification of poly (β-amino ester) s. Mol Ther. 2007;15(7):1306–12.
Anderson DG, Lynn DM, Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem (International ed. in English. 2003;42(27):3153–8.
Akinc A, Anderson DG, Lynn DM, Langer R. Synthesis of poly (β-amino ester) s optimized for highly effective gene delivery. Bioconjug Chem. 2003;14(5):979–88.
Green JJ, Zugates GT, Tedford NC, Huang YH, Griffith LG, Lauffenburger DA, et al. Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus. Adv Mater. 2007;19(19):2836–42.
Sunshine J, Green JJ, Mahon KP, Yang F, Eltoukhy AA, Nguyen DN, et al. Small-molecule end-groups of linear polymer determine cell-type gene-delivery efficacy. Adv Mater. 2009;21(48):4947–51.
Sunshine JC, Peng DY, Green JJ. Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. Mol Pharm. 2012;9(11):3375–83.
Cereso N, Pequignot MO, Robert L, Becker F, de Luca V, Nabholz N, et al. Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient. Mol Ther Methods Clin Dev. 2014;1:14011.
Sunshine JC, Akanda MI, Li D, Kozielski KL, Green JJ. Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules. 2011;12(10):3592–600.
Sunshine JC, et al. Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One. 2012;7(5):e37543–3.
Kozielski KL, Tzeng SY, Hurtado de Mendoza BA, Green JJ. Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells. ACS Nano. 2014;8(4):3232–41.
Wilson DR, Mosenia A, Suprenant MP, Upadhya R, Routkevitch D, Meyer RA, et al. Continuous microfluidic assembly of biodegradable poly(beta-amino ester)/DNA nanoparticles for enhanced gene delivery. J Biomed Mater Res A. 2017;105(6):1813–25.
Wilson DR, Routkevitch D, Wahlin KJ, Zack DJ, Quinones-Hinojosa A, Green JJ. Development of a pH sensor to probe endosomal buffering of polymeric nanoparticles effective for gene delivery. Mol Ther. 2016;24:S196.
Anderson DG, Peng W, Akinc A, Hossain N, Kohn A, Padera R, et al. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A. 2004;101(45):16028–33.
Liu H-S, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun. 1999;260(3):712–7.
Acknowledgements
We are grateful to Baranda S. Hansen for technical assistance. The authors thank the Wilmer Microscopy and Imaging Core Facility (EY001765) at Johns Hopkins for use of their confocal microscopy.
Funding
This research was supported by grants from the Maryland Stem Cell Research Fund to D.J.Z. (EY027266), NIH grant (EY024249) to D.J.Z, BrightFocus Foundation to D.J.Z., RPB Nelson Trust Award for Retinitis Pigmentosa and unrestricted funds from Research to Prevent Blindness, Inc. to D.J.Z., generous gifts from the Guerrieri Family Foundation and from Mr. and Mrs. Robert and Clarice Smith to D.J.Z., Foundation Fighting Blindness to D.J.Z., Thome Foundation to D.J.Z., Beckman Foundation to D.J.Z., NSF Graduate Research Fellowships DGE-0707427 to DRW and DGE-1232825 to YR; the Bloomberg~Kimmel Institute for Cancer Immunotherapy to JJG; the NIH (R21EY026148, R01EB022148, R01CA228133, and the Wilmer Core Grant P30 EY001765); and a Research to Prevent Blindness / Dr. H. James and Carole Free Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration to JJG.
Author information
Authors and Affiliations
Contributions
Overall conceptualization, B.M., D.R.W., D.J.Z and J.J.G; Methodology and Investigation, B.M., D.R.W., S.S.R, M.P.S., C.B., and Y.R.; Resource Generation (plasmid DNA designing and production), K.J.W., (stem cell differentiation and maintenance), S.S.R.; Writing—Original Draft, B.M., D.R.W., C.B., D.J.Z and J.J.G; Writing—Review & Editing, B.M., D.R.W., C.B., D.J.Z and J.J.G.; Funding Acquisition, D.J.Z., J.J.G., S.S.R., D.R.W., and Y.R.; Supervision and Project Administration, D.J.Z and J.J.G.
Corresponding authors
Ethics declarations
Conflict of Interest
DJZ is on the scientific advisory board of Spark Therapeutics, which is interested in developing optimized approaches for retinal gene delivery.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 11821 kb)
Rights and permissions
About this article
Cite this article
Mishra, B., Wilson, D.R., Sripathi, S.R. et al. A Combinatorial Library of Biodegradable Polyesters Enables Non-viral Gene Delivery to Post-Mitotic Human Stem Cell-Derived Polarized RPE Monolayers. Regen. Eng. Transl. Med. 6, 273–285 (2020). https://doi.org/10.1007/s40883-019-00118-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40883-019-00118-1